Uncategorized
Featured Stories
DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call
DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice
DaVita today issued the following statement in response to the U.S. Department of Health and Human Services’ Kidney Care National Plan and related remarks regarding the future of kidney care:…
DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2026, at 5:00 p.m. Eastern Time. The company…
DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care
Seven studies spanning middle molecule clearance, home dialysis and patient experience highlight DaVita’s commitment to translating innovation into better care DENVER, Oct. 15, 2026 /PRNewswire/…
DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early
Patients encouraged to confirm treatment schedules, prepare emergency supplies and contact DaVita for assistance DENVER, Oct. 8, 2026 /PRNewswire/ — As Hurricane Isaias approaches the Gulf Coast…
DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease
More than 10,000 members will get added support aimed at delaying or preventing dialysis and reducing hospitalizations DENVER, Aug. 25, 2026 /PRNewswire/ — DaVita today announced a new…
